170 related articles for article (PubMed ID: 22068196)
21. Assessing changes in third-party gross margin for a single community pharmacy.
Urick BY; Urmie JM; Doucette WR; McDonough RP
J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
[TBL] [Abstract][Full Text] [Related]
22. Impact of patient and plan design factors on switching to preferred statin therapy.
Cox ER; Kulkarni A; Henderson R
Ann Pharmacother; 2007 Dec; 41(12):1946-53. PubMed ID: 17971409
[TBL] [Abstract][Full Text] [Related]
23. Negotiating with third party payers: one community pharmacy's experience.
Fridy K; DeHart RM; Monk-Tutor MR
J Am Pharm Assoc (Wash); 2002; 42(5):780-8. PubMed ID: 12269712
[TBL] [Abstract][Full Text] [Related]
24. Attribute substitution in early enrollment decisions into Medicare prescription drug plans.
Frakt AB; Pizer SD
Health Econ; 2008 Apr; 17(4):513-21. PubMed ID: 17935198
[TBL] [Abstract][Full Text] [Related]
25. Beneficiary price sensitivity in the Medicare prescription drug plan market.
Frakt AB; Pizer SD
Health Econ; 2010 Jan; 19(1):88-100. PubMed ID: 19191252
[TBL] [Abstract][Full Text] [Related]
26. Clinic provision of contraceptive services to managed care enrollees.
Frost JJ
Fam Plann Perspect; 1998; 30(4):156-62. PubMed ID: 9711452
[TBL] [Abstract][Full Text] [Related]
27. Socioeconomic characteristics of enrollees appear to influence performance scores for medicare part D contractors.
Young GJ; Rickles NM; Chou CH; Raver E
Health Aff (Millwood); 2014 Jan; 33(1):140-6. PubMed ID: 24395946
[TBL] [Abstract][Full Text] [Related]
28. The challenge of Medicare Part D for community pharmacies.
Stone D
J Manag Care Pharm; 2009 Mar; 15(2):171-2. PubMed ID: 19236134
[No Abstract] [Full Text] [Related]
29. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
Trapskin K; Johnson C; Cory P; Sorum S; Decker C
J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
[TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical care in community pharmacies: practice and research in Denmark.
Herborg H; Sørensen EW; Frøkjaer B
Ann Pharmacother; 2007 Apr; 41(4):681-9. PubMed ID: 17389660
[TBL] [Abstract][Full Text] [Related]
31. Lipitor goes generic: business as usual or more big business?
Gill L; Santa J; Peter DL; Keehn J
Ann Intern Med; 2012 Jun; 156(12):892-3, W313. PubMed ID: 22711082
[No Abstract] [Full Text] [Related]
32. Comparison of Discounted and Undiscounted Cash Prices for Cardiovascular Medications by Type of US Community Pharmacy.
Hong M; Shcherbakova N
J Gen Intern Med; 2021 Jan; 36(1):114-120. PubMed ID: 32885368
[TBL] [Abstract][Full Text] [Related]
33. Independently owned pharmacy closures in rural America.
Boyle K; Ullrich F; Mueller K
Rural Policy Brief; 2012 Jul; (2012 4):1-4. PubMed ID: 22830100
[TBL] [Abstract][Full Text] [Related]
34. How might the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 affect the financial viability of rural pharmacies? An analysis of preimplementation prescription volume and payment sources in rural and urban areas.
Fraher EP; Slifkin RT; Smith L; Randolph R; Rudolf M; Holmes GM
J Rural Health; 2005; 21(2):114-21. PubMed ID: 15859048
[TBL] [Abstract][Full Text] [Related]
35. Pharmaceutical care in community pharmacies: practice and research in the US.
Christensen DB; Farris KB
Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting the unmet demand for pharmacists: state-level analysis.
Taylor TN; Knapp KK; Barnett MJ; Shah BM; Miller L
J Am Pharm Assoc (2003); 2013; 53(4):373-81. PubMed ID: 23892810
[TBL] [Abstract][Full Text] [Related]
37. Independently owned pharmacy closures in rural America, 2003-2010.
Boyle K; Ullrich F; Mueller K
Rural Policy Brief; 2011 Jun; (2011 5):1-4. PubMed ID: 21736184
[TBL] [Abstract][Full Text] [Related]
38. The value of atorvastatin over the product life cycle in the United States.
Grabner M; Johnson W; Abdulhalim AM; Kuznik A; Mullins CD
Clin Ther; 2011 Oct; 33(10):1433-43. PubMed ID: 21955936
[TBL] [Abstract][Full Text] [Related]
39. Impact of restricted reimbursement on the use of statins in Finland: a register-based study.
Martikainen JE; Saastamoinen LK; Korhonen MJ; Enlund H; Helin-Salmivaara A
Med Care; 2010 Sep; 48(9):761-6. PubMed ID: 20706164
[TBL] [Abstract][Full Text] [Related]
40. Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008.
Walberg MP; Patel RA; Amaral MM
J Med Econ; 2008; 11(4):625-37. PubMed ID: 19450072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
